Condensed Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 39,559	$ 124,014
Short-term investments	144,531	34,671
Accounts receivable, net	34,891	35,619
Inventories	52,249	59,387
Prepaid expenses and other current assets	4,348	4,530
Total current assets	275,578	258,221
Restricted cash	3,329	3,329
Property and equipment, net	6,166	8,133
Operating lease right-of-use assets	3,168	3,940
Other assets	560	2,172
Total assets	288,801	275,795
Current liabilities:
Accounts payable	1,445	3,862
Accrued compensation and related benefits	9,789	16,821
Accrued expenses and other current liabilities	8,518	8,205
Accrued warranty liability	1,239	1,938
Deferred revenue, current	14,009	12,753
Operating lease liabilities, current	1,909	1,799
Total current liabilities	36,909	45,378
Accrued interest	0	2,695
Deferred revenue	587	844
Operating lease liabilities	1,707	2,684
Term loan	94,814	197,375
Total liabilities	134,017	248,976
Commitments and contingencies (Note 6)
Stockholders' equity:
Preferred stock, $0.001 par value; 5,000 shares authorized, and no shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively	3,841	0
Common stock, $0.001 par value; 300,000 shares authorized as of June 30,2025 and December 31, 2024; 17,766 and 3,530 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively	18	4
Additional paid-in capital	1,284,923	1,116,496
Accumulated other comprehensive loss	49	42
Accumulated deficit	(1,134,047)	(1,089,723)
Total stockholders' equity	154,784	26,819
Total liabilities and stockholders' equity	$ 288,801	$ 275,795